Home
About
FAQ
History (10)
The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo.
Weight regain is related to decreases in physical activity during weight loss.
Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells.
Clostridium Infections
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.
Shapiro MD, Fazio S. Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering. Nat Rev Cardiol. 2017 06; 14(6):319-320.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Anticholesteremic Agents
Cardiovascular Diseases
Cholesterol, LDL
Clinical Trials as Topic
Dyslipidemias
Humans
Pharmacogenetics
authors with profiles
Michael D. Shapiro DO, MCR